Abstract:Objective: To evaluate and compare the performance of walking disability scale with neurogenic claudication (NC) due to Lumbar Spinal Stenosis (LSS). Methods: We searched 6 databases and constructed a document database of the study on the performance of the measurement tools for low back pain outcomes, and included the validity study of low back pain population to evaluate the measurement performance of at least one scale. Two researchers selected and extracted full-text data based on inclusion and exclusion criteria, respectively. Sample size, age, sex, disease characteristics, region and language were extracted for each study, as well as statistical methods and study results of measurement performance. The measurement properties evaluation criteria was used to evaluate the quality of the scales, and the items contained in the corresponding boxes of the COSMIN standard were used to evaluate each measurement performance. The evidence level of the scale is evaluated based on the consistency of all the research results of each measurement performance and the quality of the research methodology. Results: A database containing 123 articles was established. After full text reading, 10 validity studies were extracted, including 11 measurements. According to the COSMIN standard, the methodological quality of 7 studies was rated as excellent, 4 as good, 6 as fair, and 2 as poor. The overall evidence showed that: the scale with good internal consistency included PFS, the scale with good test-retest reliability included PFS, PFS walk, ODI walk, the scale with good structure validity included HUI3 AMb, OCS-spd, Self-predicted walking short and ODI walk; the scale with good criterion validity included HUI3 AMb, and the response validity was affected by the quality of research methodology, so there is no good scale. Conclusion: At present, there is a lack of high-quality research on the measurement properties of walking disability for NC patients, or no measurements can be used as the gold standard for NC evaluation. Available evidence recommends that clinicians and researchers use ODI Walk as a measurement tool to evaluate NC. The high-quality studies with rigorous design and large sample size are warranted in future.